Voice your opinion on congressional bill HR7497-117 and let lawmakers know your stance with UnPac!

Main Subject: Health

Make Medicine Affordable Act

This bill establishes several programs and requirements to address the prices of prescription drugs, including (1) requiring the Centers for Medicare & Medicaid Services to negotiate the prices of certain brand-name drugs and insulin under Medicare, (2) capping annual out-of-pocket spending under the Medicare prescription drug benefit, and (3) limiting cost-sharing for insulin products.

HR2815-117, HR6833-117, HR5376-117,

House committee actions Actions

Committee
Apr. 12 2022	Referred to the Subcommittee on Health.

House floor actions Actions

IntroReferral

Apr. 11
2022

Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Library of Congress Actions

IntroReferral
Apr. 11 2022	Introduced in House Introduced in House

House bill HR7497-117

To provide for lower prices for drugs through drug price negotiation, and for other purposes.

House bill HR7497-117

To provide for lower prices for drugs through drug price negotiation, and for other purposes.

Promote the cause!

Or use this QR code